| OAAIX | PXQIX | OAAIX / PXQIX | |
| Total Expense Ratio | 0.84 | 0.55 | 153% |
| Annual Report Gross Expense Ratio | 0.84 | 0.55 | 153% |
| Fund Existence | 21 years | 7 years | - |
| Gain YTD | 11.678 | 11.806 | 99% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 959M | 959M | 100% |
| Annual Yield % from dividends | 1.15 | 1.40 | 82% |
| Returns for 1 year | 15.64 | 15.95 | 98% |
| Returns for 3 years | 35.10 | 36.48 | 96% |
| Returns for 5 years | 12.33 | 14.09 | 88% |
| Returns for 10 years | 29.78 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NBGX | 28.91 | 0.43 | +1.50% |
| Neuberger Growth ETF | |||
| EWZS | 13.21 | -0.03 | -0.23% |
| iShares MSCI Brazil Small-Cap ETF | |||
| FTXL | 216.54 | -1.28 | -0.59% |
| First Trust Nasdaq Semiconductor ETF | |||
| EMET | 38.86 | -0.31 | -0.78% |
| VanEck Copper and ElectrificationMtlsETF | |||
| HELX | 38.83 | -0.92 | -2.30% |
| Franklin Genomic Advancements ETF | |||